How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise
In this episode of the DeviceTalks Weekly podcast, Mobia Medical CEO Richard Foust explains how the “magical” qualities of the company’s neurotechnology helped steer it toward an IPO. Mobia Medical’s implantable pulse generator promotes motor skill recovery in patients who have suffered a stroke. The company’s early commercial success has generated modest revenue, but Foust tells host Tom Salemi that “not all revenue is the same,” explaining why a large, untapped and growing market won over venture capital investors a few years ago and public investors this spring.
MassDevice Editor Chris Newmarker returns with another edition of Newmarker’s Newsmakers. Tom and Chris repeatedly lament the departure of former Senior Editor Sean Whooley, who recently left MassDevice to pursue other opportunities. Despite his departure, Sean’s reporting remains front and center, as he wrote all five featured stories covering Danaher, Medtronic, Boston Scientific, Integer, Teleflex, and private equity investors.
Special thanks to our sponsors of MassDevice’s Diabetes Technology Innovations Special Report: Cadence, Jabil, and Viant Medical! Download the complimentary report here: https://www.massdevice.com/diabetes-technology-innovations-special-report-2026/
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
